OP021 Autologous haematopoietic stem cell transplantation for Crohn’s disease: a retrospective study from the European Society for Blood Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (original) (raw)

Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study

Kathryn Sexton

Gut, 2020

View PDFchevron_right

The Treatment-Naive Microbiome in New-Onset Crohn’s Disease

Jeffrey Hyams, Sandra Kim

Cell Host & Microbe, 2014

View PDFchevron_right

Alteration of the Gut Microbiome for Patients with Inflammatory Bowel Disease: A Review

Sherif Edris

Applied Ecology and Environmental Research, 2020

View PDFchevron_right

Gut mucosal-associated microbiota better discloses inflammatory bowel disease differential patterns than faecal microbiota

lorenza putignani

Digestive and Liver Disease, 2018

View PDFchevron_right

Fecal Microbial Composition of Ulcerative Colitis and Crohn’s Disease Patients in Remission and Subsequent Exacerbation

Paul Savelkoul

PLoS ONE, 2014

View PDFchevron_right

Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease

Inge Nordgaard-Lassen

Frontiers in Medicine, 2018

View PDFchevron_right

Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort study

Rupert Leong

BMJ Open, 2021

View PDFchevron_right

Dominant fecal microbiota in newly diagnosed untreated inflammatory bowel disease patients

Petr Ricanek

2013

View PDFchevron_right

Human Gut Microbiome Transplantation in Ileitis Prone Mice: A Tool for the Functional Characterization of the Microbiota in Inflammatory Bowel Disease Patients

abdullah osme

Inflammatory Bowel Diseases, 2019

View PDFchevron_right

Specificities of the fecal microbiota in inflammatory bowel disease

Joël Doré

Inflammatory Bowel Diseases, 2006

View PDFchevron_right

High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease

Barry Hudspith

BMC Microbiology, 2011

View PDFchevron_right

The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease

Fabio Cominelli

Gut, 2023

View PDFchevron_right

Landscapes and bacterial signatures of mucosa-associated intestinal microbiota in Chilean and Spanish patients with inflammatory bowel disease

Nayaret Chamorro

Microbial Cell, 2021

View PDFchevron_right

Studying the enteric microbiome in inflammatory bowel diseases: getting through the growing pains and moving forward

Vincent Young

Front Microbiol, 2011

View PDFchevron_right

Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohnʼs disease

Janet Jansson

Inflammatory Bowel Diseases, 2009

View PDFchevron_right

Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohnʼs Disease

Joshua Korzenik

Inflammatory Bowel Diseases, 2016

View PDFchevron_right

Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn’s disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets

Babak Khorsand

Frontiers in Cellular and Infection Microbiology, 2022

View PDFchevron_right

Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota

Elizabeth Lund

BMC Gastroenterology, 2010

View PDFchevron_right

Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid

Srinivasan Pugazhendhi

Indian Journal of Medical Research, 2015

View PDFchevron_right

Faculty of 1000 evaluation for The treatment-naive microbiome in new-onset Crohn's disease

Morten Vatn

F1000 - Post-publication peer review of the biomedical literature, 2015

View PDFchevron_right

The Impact of Microbiome Interventions on the Progression and Severity of Inflammatory Bowel Disease: A Systematic Review

sobia nawaz

Curēus, 2024

View PDFchevron_right

P846 Comparative study of faecal microbiota in Crohn’s disease patients in remission with and without surgical resection

Anna Bahí

Journal of Crohn's and Colitis, 2020

View PDFchevron_right

Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray

Joël Doré, Marion Leclerc

2010

View PDFchevron_right

Analysis of bacterial bowel communities of IBD patients: What has it revealed?

Gerald Tannock

Inflammatory Bowel Diseases, 2008

View PDFchevron_right

Exploring how microbiome signatures change across inflammatory bowel disease conditions and disease locations

Sjoerd Rijpkema

Scientific Reports, 2021

View PDFchevron_right

Features of Fecal and Colon Microbiomes Associate With Responses to Biologic Therapies for Inflammatory Bowel Diseases: A Systematic Review

Cátia Rocha

Clinical Gastroenterology and Hepatology, 2019

View PDFchevron_right

Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease

Fumihito Hirai

Journal of Gastroenterology, 2012

View PDFchevron_right

Unstable Composition of the Fecal Microbiota in Ulcerative Colitis During Clinical Remission

Maria Antolin, Cristina Martínez

The American Journal of Gastroenterology, 2008

View PDFchevron_right

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

Joël Doré

Gut, 2006

View PDFchevron_right

The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease

A. Acharjee

Therapeutic Advances in Gastroenterology, 2019

View PDFchevron_right

Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease

Daryl Tang

Intestinal Research

View PDFchevron_right

Microbial Signatures as a Predictive Tool in IBD—Pearls and Pitfalls

Amira Metwaly

Inflammatory Bowel Diseases

View PDFchevron_right